Choline metabolism in malignant transformation K Glunde, ZM Bhujwalla, SM Ronen Nature Reviews Cancer 11 (12), 835-848, 2011 | 828 | 2011 |
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer K Glunde, C Jie, ZM Bhujwalla Cancer research 64 (12), 4270-4276, 2004 | 450 | 2004 |
Choline phospholipid metabolism: a target in cancer cells? E Ackerstaff, K Glunde, ZM Bhujwalla Journal of cellular biochemistry 90 (3), 525-533, 2003 | 386 | 2003 |
Extracellular acidification alters lysosomal trafficking in human breast cancer cells K Glunde, SE Guggino, M Solaiyappan, AP Pathak, Y Ichikawa, ... Neoplasia 5 (6), 533-545, 2003 | 340 | 2003 |
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells E Iorio, A Ricci, M Bagnoli, ME Pisanu, G Castellano, M Di Vito, ... Cancer research 70 (5), 2126-2135, 2010 | 226 | 2010 |
Choline metabolism in cancer: implications for diagnosis and therapy K Glunde, MA Jacobs, ZM Bhujwalla Expert review of molecular diagnostics 6 (6), 821-829, 2006 | 222 | 2006 |
RNA interference–mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation K Glunde, V Raman, N Mori, ZM Bhujwalla Cancer research 65 (23), 11034-11043, 2005 | 211 | 2005 |
Targeting phospholipid metabolism in cancer M Cheng, ZM Bhujwalla, K Glunde Frontiers in oncology 6, 266, 2016 | 192 | 2016 |
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism K Glunde, NJ Serkova Pharmacogenomics 7 (7), 1109-1123, 2006 | 180 | 2006 |
Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1α signaling in a human prostate cancer model K Glunde, T Shah, PT Winnard Jr, V Raman, T Takagi, F Vesuna, ... Cancer research 68 (1), 172-180, 2008 | 164 | 2008 |
Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions K Glunde, E Ackerstaff, N Mori, MA Jacobs, ZM Bhujwalla Molecular pharmaceutics 3 (5), 496-506, 2006 | 160 | 2006 |
Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models [S] K Chughtai, L Jiang, TR Greenwood, K Glunde, RMA Heeren Journal of lipid research 54 (2), 333-344, 2013 | 159 | 2013 |
Metabolic tumor imaging using magnetic resonance spectroscopy K Glunde, ZM Bhujwalla Seminars in oncology 38 (1), 26-41, 2011 | 148 | 2011 |
PSMA-targeted theranostic nanoplex for prostate cancer therapy Z Chen, MF Penet, S Nimmagadda, C Li, SR Banerjee, PT Winnard Jr, ... ACS nano 6 (9), 7752-7762, 2012 | 140 | 2012 |
Concise representation of mass spectrometry images by probabilistic latent semantic analysis M Hanselmann, M Kirchner, BY Renard, ER Amstalden, K Glunde, ... Analytical chemistry 80 (24), 9649-9658, 2008 | 137 | 2008 |
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer K Glunde, D Artemov, MF Penet, MA Jacobs, ZM Bhujwalla Chemical reviews 110 (5), 3043-3059, 2010 | 134 | 2010 |
Metabolomics of cancer NJ Serkova, K Glunde Tumor Biomarker Discovery: Methods and Protocols, 273-295, 2009 | 123 | 2009 |
Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments W Liu, K Glunde, ZM Bhujwalla, V Raman, A Sharma, JM Phang Cancer research 72 (14), 3677-3686, 2012 | 122 | 2012 |
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer K Sonkar, V Ayyappan, CM Tressler, O Adelaja, R Cai, M Cheng, ... NMR in Biomedicine 32 (10), e4112, 2019 | 120 | 2019 |
Choline metabolism-based molecular diagnosis of cancer: an update K Glunde, MF Penet, L Jiang, MA Jacobs, ZM Bhujwalla Expert review of molecular diagnostics 15 (6), 735-747, 2015 | 120 | 2015 |